MS Views and News Be empowered with MS views and news. To receive The MS BEACON e-Newsletter, CLICK HERE - -

Please visit our MS learning channel on YouTube, which provides hundreds of MS videos presented by MS Experts across the USA, from many of our recorded education programs. Archived here: -- Additionally, please visit our Social media platforms: Facebook, Twitter, and Instagram

Important Resources for the MS community are found on the left side of this blog.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, for your personal knowledge and to keep you informed of current health-related issues. It is not a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.


Tuesday, April 10, 2018

RRMS: What You Need to Know About Switching Medications

Relapse-remitting multiple sclerosis (RRMS) is the most common form of multiple sclerosis (MS). You may have periods where no symptoms occur (remittance), followed by bouts of worsening symptoms (relapse). Sometimes the symptoms become permanent during remittance.
As inflammation chronically affects the central nervous system, symptoms and overall disease progression can be difficult to predict. With RRMS, the symptoms may worsen over time. Subsequently, your treatment plan may require modification.
Based on your symptoms, you may be thinking about switching your medications. While switching RRMS medications might be helpful, this isn’t necessarily a smooth transition. Before you stop your current treatment plan and start up another one, be sure to discuss safety considerations and the possibility of worsening symptoms with your doctor. You will also need to understand all dosing information.

Why you may need to switch medications

SUBSCRIBE to our MS Learning Channel on YouTube: 

No comments: